Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Polycythemia Vera × Phlebotomy × Clear all

Phase

Status

Completed 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombosis 1 Polycythemia Vera 1 Polycythemia 1 Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

fludarabine phosphate 5 Cyclophosphamide 4 Whole-Body Irradiation 3 Cyclosporine 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 fludarabine 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Methylprednisolone 2 Busulfan 2 Antilymphocyte Serum 2 nelarabine 1 fresolimumab 1 Watchful Waiting 1 Thiotepa 1 Tetradecanoylphorbol Acetate 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 RG7388 1 Phlebotomy 1 Oxycodone 1 Observation 1 Nivolumab 1 N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1 Mycophenolic Acid 1 Moxifloxacin 1 Morphine 1 Methotrexate 1 Methadone 1 Leucovorin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡